FDA Approves Clinical Studies Of A Novel Anti-Cancer Drug, CDC7 Inhibitor, Developed By Italian Researchers (Medical News Today)
Nerviano Medical Sciences (NMS) has secured Food and Drug Administration (FDA) approval to conduct for the first time clinical trials of a novel antitumoral agent. The drug blocks Cdc7, a protein that is responsible for the uncontrolled proliferation of cancer cells.

J&J Ejaculation Pill, World s First, Wins Approvals (Update1) (Bloomberg)
Feb. 10 (Bloomberg) -- Johnson & Johnson won approval in Sweden and Finland for the first prescription pill to treat premature ejaculation, three years after U.S. regulators rejected the drug, the company said.